A pilot study of hypofractionated nodal irradiation for postoperative breast cancer
Not Applicable
Recruiting
- Conditions
- Breast cancer
- Registration Number
- JPRN-UMIN000051553
- Lead Sponsor
- Hyogo Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with malignancy other than breast cancer, infective disease requiring systemic therapy, fever (> 100 F), diabetes mellitus (HbA1c => 7.0 %), lung fibrosis/interstitial lung disease/severe emphysema, active collagen vascular disease, or genetic disorders high-risk for radiation. Patients who are (possibly) pregnant, breast feeding, receiving systemic steroids or immune-suppression therapy, planned to have breast reconstruction surgery, unable to raise her/his arms above shoulders, or receiving radiation therapy including internal mammary node region.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acute or subacute adverse events of CTACE grade 2+ occurring within 6 months from radiation therapy completion
- Secondary Outcome Measures
Name Time Method